The diagnostic test is based on technology being developed by Antigen Express. The technology being developed at Antigen Express allows for more potent and specific activation of immune cells, both after immunization and using blood cells ex vivo, said Generex.
In type 1 diabetes, these cells become aberrantly activated to recognize proteins associated with cells involved in insulin secretion, which ultimately leads to the destruction of these cells. Antigen Express technology allows for the more sensitive detection of these inappropriately activated cells in the blood, according to Generex.